This site is intended for health professionals only

Home / News / News in Brief / Hepatitis C cured in less than two months

Hepatitis C cured in less than two months

20 Feb 2015

An experimental drug cocktail has been found to eradicate Hepatitis C after six weeks of therapy.

Achillion Pharmacutical Inc’s hepatitis C drug, when used together with Gilead Sciences Inc’s Sovaldi, removed viral signs after six weeks.

This result bettered Gilead’s own hepatitis C treatment which managed the same amount of viral reduction after eight weeks.

Achillion’s ongoing mid-stage study is aiming to achieve a sustained virological response 12 weeks after therapy, which is considered a cure.

It was achieved by using a 50mg dose of Achillion’s NS5a inhibitor in combination with 400mg of Gileads’ sofosbuvir in previously untreated genotype 1 hepatitis C patients.

Achillion CEO Milind Deshpande said the data represents the “shortest duration and highest response” achieved with any two drug, direct acting antiviral regime for hepatitis C.

It is claimed hepatitis C affects 150m people worldwide.

Almost 50% of people who inject drugs in England are believed to have the disease. Hepatitis C is usually transmitted through blood to blood contact – through sharing razors, toothbrushes or sharing unsterilised needles.

Want news like this straight to your inbox?

Latest News

Nitin Sodha steps down from NPA board after 12 years
Nitin Sodha has stepped down from the National Pharmacy Association (NPA) board after 12 years,...
How to make more money from vaccination services
There are many different vaccination services that you can offer in your pharmacy – from...
Commissioners must back more pharmacies to offer sexual health services, Public Health England urges
Local commissioners should provide funding for more community pharmacies to offer sexual health services including...